The coming of age of adoptive T-cell therapy for viral infection after stem cell transplantation

doi:10.3978/j.issn.2305-5839.2015.01.18

. 2015 Apr;3(5):62.

doi: 10.3978/j.issn.2305-5839.2015.01.18.

The coming of age of adoptive T-cell therapy for viral infection after stem cell transplantation

Austin John Barrett¹, Catherine M Bollard¹

Affiliations

Affiliation

¹ 1 National Heart Lung and Blood Institute (NHLBI), National Institutes of Health, Bethesda, MD, USA ; 2 Children's National Health System and The George Washington University, Washington, DC, USA.

PMID: 25992361
PMCID: PMC4402608
DOI: 10.3978/j.issn.2305-5839.2015.01.18

The coming of age of adoptive T-cell therapy for viral infection after stem cell transplantation

Austin John Barrett et al. Ann Transl Med. 2015 Apr.

. 2015 Apr;3(5):62.

doi: 10.3978/j.issn.2305-5839.2015.01.18.

Authors

Austin John Barrett¹, Catherine M Bollard¹

Affiliation

¹ 1 National Heart Lung and Blood Institute (NHLBI), National Institutes of Health, Bethesda, MD, USA ; 2 Children's National Health System and The George Washington University, Washington, DC, USA.

PMID: 25992361
PMCID: PMC4402608
DOI: 10.3978/j.issn.2305-5839.2015.01.18

No abstract available

PubMed Disclaimer

Cited by

Cytomegalovirus in Haematological Tumours.
Alonso-Álvarez S, Colado E, Moro-García MA, Alonso-Arias R. Alonso-Álvarez S, et al. Front Immunol. 2021 Oct 18;12:703256. doi: 10.3389/fimmu.2021.703256. eCollection 2021. Front Immunol. 2021. PMID: 34733270 Free PMC article. Review.
MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.
La Rosa C, Longmate J, Martinez J, Zhou Q, Kaltcheva TI, Tsai W, Drake J, Carroll M, Wussow F, Chiuppesi F, Hardwick N, Dadwal S, Aldoss I, Nakamura R, Zaia JA, Diamond DJ. La Rosa C, et al. Blood. 2017 Jan 5;129(1):114-125. doi: 10.1182/blood-2016-07-729756. Epub 2016 Oct 19. Blood. 2017. PMID: 27760761 Free PMC article. Clinical Trial.
Rapid cloning, expression, and functional characterization of paired αβ and γδ T-cell receptor chains from single-cell analysis.
Guo XZ, Dash P, Calverley M, Tomchuck S, Dallas MH, Thomas PG. Guo XZ, et al. Mol Ther Methods Clin Dev. 2016 Jan 27;3:15054. doi: 10.1038/mtm.2015.54. eCollection 2016. Mol Ther Methods Clin Dev. 2016. PMID: 26858965 Free PMC article.
Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.
Mehta RS, Rezvani K. Mehta RS, et al. Virulence. 2016 Nov 16;7(8):901-916. doi: 10.1080/21505594.2016.1208866. Epub 2016 Jul 6. Virulence. 2016. PMID: 27385018 Free PMC article. Review.
Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection.
Ouellette CP. Ouellette CP. Viruses. 2022 Oct 27;14(11):2370. doi: 10.3390/v14112370. Viruses. 2022. PMID: 36366468 Free PMC article. Review.

See all "Cited by" articles

References

1. Jain NA, Lu K, Ito S, et al. The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approaches. Cytotherapy 2014;16:927-33. - PMC - PubMed
1. Riddell SR, Watanabe KS, Goodrich JM, et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992;257:238-41. - PubMed
1. Heslop HE, Brenner MK, Rooney CM. Donor T cells to treat EBV-associated lymphoma. N Engl J Med 1994;331:679-80. - PubMed
1. Heslop HE, Slobod KS, Pule MA, et al. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood 2010;115:925-35. - PMC - PubMed
1. Doubrovina E, Oflaz-Sozmen B, Prockop SE, et al. Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. Blood 2012;119:2644-56. - PMC - PubMed

Grants and funding

P01 CA148600/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources

[1] Jain NA, Lu K, Ito S, et al. The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approaches. Cytotherapy 2014;16:927-33. - PMC - PubMed

[2] Jain NA, Lu K, Ito S, et al. The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approaches. Cytotherapy 2014;16:927-33. - PMC - PubMed

[3] Riddell SR, Watanabe KS, Goodrich JM, et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992;257:238-41. - PubMed

[4] Riddell SR, Watanabe KS, Goodrich JM, et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992;257:238-41. - PubMed

[5] Heslop HE, Brenner MK, Rooney CM. Donor T cells to treat EBV-associated lymphoma. N Engl J Med 1994;331:679-80. - PubMed

[6] Heslop HE, Brenner MK, Rooney CM. Donor T cells to treat EBV-associated lymphoma. N Engl J Med 1994;331:679-80. - PubMed

[7] Heslop HE, Slobod KS, Pule MA, et al. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood 2010;115:925-35. - PMC - PubMed

[8] Heslop HE, Slobod KS, Pule MA, et al. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood 2010;115:925-35. - PMC - PubMed

[9] Doubrovina E, Oflaz-Sozmen B, Prockop SE, et al. Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. Blood 2012;119:2644-56. - PMC - PubMed

[10] Doubrovina E, Oflaz-Sozmen B, Prockop SE, et al. Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. Blood 2012;119:2644-56. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The coming of age of adoptive T-cell therapy for viral infection after stem cell transplantation

Affiliation

The coming of age of adoptive T-cell therapy for viral infection after stem cell transplantation

Authors

Affiliation

Similar articles

Cited by

References

Grants and funding

LinkOut - more resources

Full Text Sources